김영선

Directeur

OtherF

KR·DART (FSS)

동국생명과학 동국생명과학

0

Total declarations

0

Companies

—

▲ Purchases (0 ops.)

—

▼ Sales (0 ops.)

Discover the complete record of transactions filed by 김영선, Directeur. Insider active across 2 companies, notably 동국생명과학. Cumulatively, 1 filings have been logged. The latest transaction was disclosed on 8 April 2026 — Purchase. Regulator: DART (FSS). All data is free.

Declarations1 total

Executives●Purchase동동국생명과학19DART

김

김영선상무

€19,28510,000 shares@ €1.92850.0000% mcap100.0% of flow

ShareKRX

DART:20260409001626·8 Apr 2026

Ideal exit: 3 Jan 2027 (T+270)

DART ↗

1 of 1 declaration

About 김영선

Kim Young-sun is an Executive Director at Dongguk Life Science, a company active in the life sciences field. In this role, he oversees operations and contributes to product development strategy. Kim Young-sun is recognized for his expertise in the sector and for his ability to lead teams toward innovation. His commitment to quality and efficiency is essential for Dongguk Life Science's success.